These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 2580959)
1. Antigenic heterogeneity of human anaplastic gliomas and glioma-derived cell lines defined by monoclonal antibodies. Wikstrand CJ; Grahmann FC; McComb RD; Bigner DD J Neuropathol Exp Neurol; 1985 May; 44(3):229-41. PubMed ID: 2580959 [TBL] [Abstract][Full Text] [Related]
2. Five new epitope-defined monoclonal antibodies reactive with GM2 and human glioma and medulloblastoma cell lines. Vrionis FD; Wikstrand CJ; Fredman P; Månsson JE; Svennerholm L; Bigner DD Cancer Res; 1989 Dec; 49(23):6645-51. PubMed ID: 2479468 [TBL] [Abstract][Full Text] [Related]
3. Antigenic heterogeneity of human colorectal cancer cell lines analyzed by a panel of monoclonal antibodies. I. Heterogeneous expression of Ia-like and HLA-like antigenic determinants. MacLean GD; Seehafer J; Shaw AR; Kieran MW; Longenecker BM J Natl Cancer Inst; 1982 Aug; 69(2):357-64. PubMed ID: 6180206 [TBL] [Abstract][Full Text] [Related]
4. Demonstration of complex antigenic heterogeneity in a human glioma cell line and eight derived clones by specific monoclonal antibodies. Wikstrand CJ; Bigner SH; Bigner DD Cancer Res; 1983 Jul; 43(7):3327-34. PubMed ID: 6303581 [TBL] [Abstract][Full Text] [Related]
5. Phenotyping of 60 cultured human gliomas and 34 other neuroectodermal tumors by means of monoclonal antibodies against glioma, melanoma and HLA-DR antigens. de Muralt B; de Tribolet N; Diserens AC; Stavrou D; Mach JP; Carrel S Eur J Cancer Clin Oncol; 1985 Feb; 21(2):207-16. PubMed ID: 2985398 [TBL] [Abstract][Full Text] [Related]
6. Characterization of three restricted specificity monoclonal antibodies raised against the human glioma cell line D-54 MG. Wikstrand CJ; Bigner SH; Bigner DD J Neuroimmunol; 1984 Jun; 6(3):169-86. PubMed ID: 6373821 [TBL] [Abstract][Full Text] [Related]
7. Production and characterization of two human glioma xenograft-localizing monoclonal antibodies. Wikstrand CJ; McLendon RE; Bullard DE; Fredman P; Svennerholm L; Bigner DD Cancer Res; 1986 Nov; 46(11):5933-40. PubMed ID: 3756930 [TBL] [Abstract][Full Text] [Related]
8. Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody. Bourdon MA; Wikstrand CJ; Furthmayr H; Matthews TJ; Bigner DD Cancer Res; 1983 Jun; 43(6):2796-805. PubMed ID: 6342760 [TBL] [Abstract][Full Text] [Related]
9. Expression of HLA-DR and common acute lymphoblastic leukemia antigens on glioma cells. Carrel S; De Tribolet N; Gross N Eur J Immunol; 1982 Apr; 12(4):354-7. PubMed ID: 6954072 [TBL] [Abstract][Full Text] [Related]
10. Surface antigenic characteristics of human glial brain tumor cells. Wikstrand CJ; Mahaley MS; Bigner DD Cancer Res; 1977 Dec; 37(12):4267-75. PubMed ID: 72598 [TBL] [Abstract][Full Text] [Related]
11. Reactivity of antiglioma monoclonal antibodies for a large panel of cultured gliomas and other neuroectoderm derived tumors. de Muralt B; de Tribolet N; Diserens AC; Carrel S; Mach JP Anticancer Res; 1983; 3(1):1-6. PubMed ID: 6830147 [TBL] [Abstract][Full Text] [Related]
12. Human fetal brain antigen expression common to tumors of neuroectodermal tissue origin. Wikstrand CJ; Bourdon MA; Pegram CN; Bigner DD J Neuroimmunol; 1982 Aug; 3(1):43-62. PubMed ID: 6284796 [TBL] [Abstract][Full Text] [Related]
13. Expression of neuroectodermal antigens common to melanomas, gliomas, and neuroblastomas. I. Identification by monoclonal anti-melanoma and anti-glioma antibodies. Carrel S; de Tribolet N; Mach JP Acta Neuropathol; 1982; 57(2-3):158-64. PubMed ID: 6181646 [TBL] [Abstract][Full Text] [Related]
14. Morphological heterogeneity and phenotype modifications during long term in vitro cultures of six new human glioblastoma cell lines. Dipasquale B; Colombatti M; Tridente G Tumori; 1990 Apr; 76(2):172-8. PubMed ID: 2330609 [TBL] [Abstract][Full Text] [Related]
15. Expression of human fetal brain antigens by human tumors of neuroectodermal origin as defined by monoclonal antibodies. Wikstrand CJ; Bigner DD Cancer Res; 1982 Jan; 42(1):267-75. PubMed ID: 6274512 [TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies reactive with glioma cell lines derived from experimental brain tumors. Stavrou D; Süss C; Bilzer T; Kummer U; De Tribolet N Eur J Cancer Clin Oncol; 1983 Oct; 19(10):1439-49. PubMed ID: 6196200 [TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies in neuro-oncology. Stavrou D Neurosurg Rev; 1990; 13(1):7-18. PubMed ID: 2181345 [TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibodies to human melanoma associated antigens: study of their specificity and visualization at the cellular level of the antigenic distribution. Libert A; Ghanem G; Arnould R; Vercammen-Grandjean A; Carrel S; Lejeune F Anticancer Res; 1983; 3(4):219-25. PubMed ID: 6576727 [TBL] [Abstract][Full Text] [Related]
19. Common antigenic determinants on human melanoma, glioma, neuroblastoma, and sarcoma cells defined with monoclonal antibodies. Seeger RC; Rosenblatt HM; Imai K; Ferrone S Cancer Res; 1981 Jul; 41(7):2714-7. PubMed ID: 6166367 [TBL] [Abstract][Full Text] [Related]
20. Reactivity of monoclonal antibodies against human leucocyte antigens with lymphocytes of non-human primate origin. Neubauer RH; Levy R; Strnad BC; Rabin H J Immunogenet; 1981 Dec; 8(6):433-42. PubMed ID: 6801142 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]